What can the UK’s response to the pandemic teach us about wider science and technology policy?
The last eighteen months has demonstrated the value of deeply embedded relationships between public and private sectors, built over decades and crystallised through the catapults and innovation institutions established in the 2017 Industrial Strategy and Life Sciences Industrial Strategy. This system proved its value during coronavirus, not only to develop the vaccine but also to sequence the virus, understand the mutation of the disease and develop testing at both an individual and population level.
This event will consider what lessons we can draw from the institutions and networks that successfully mobilised to fight the pandemic, and how we can learn from them in other sectors of the economy. This will include a discussion on the role of ARIA, to ensure it fulfils its potential as the engine of innovative, high risk research, and consider the wider questions posed by the Nurse Review.
In person events are a great way to engage with experts, industry professionals and parliamentarians on the subject. If you are interested in attending this event, please email email@example.com
If you would like to watch online, please sign up below.
George Freeman MP, Minister for Science, Research and Innovation
Baroness Blackwood, Chair, Genomics England
Dr Amanda Lamb, Chief Operations Officer, The Pandemic Institute
Dr Lorna Meldrum, Vice President, International Markets and Pandemic Response, Seqirus